Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096286885> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W3096286885 endingPage "538" @default.
- W3096286885 startingPage "538" @default.
- W3096286885 abstract "Cisplatin is one of the major drugs that used in the treatment of oral cancer.Excision repair cross-complementation group 1 (ERCC1) is a key DNA repair gene in the nucleotide excision repair pathway which is activated in the repair of intra- and interstrand DNA crosslink caused by platinum-based treatment. The aim of this study was to investigate the association between polymorphisms in ERCC1 (C118T & C8092A) genes and the response to cisplatin-based chemotherapy.ERCC1polymorphisms (C118T & C8092A) were studied using PCR-RFLP method from 150 OSCC patients as cases as well as 150 normal tissues from the same patients were collected as controls for this study. Results: Frequencies of ERCC1 C118C, C118T and T118T genotypes were 60%, 28% and 12% in OSCC patients and 78%, 19% and 3% in the controls, respectively. The C118T & T118T genotype had a 1.69 and 4.97 -folds increased risk for OSCC. Frequencies of ERCC1 C8092C, C8092A and A8092A were 78%, 18% and 4% in the OSCC patients and 89%, 10%, amd 1% in the controls, respectively. The C8092A genotype showed a 1.97-fold increased risk for OSCC.In conclusion, this study highlights the DNA repair gene polymorphisms that might play a role in mediating susceptibility to oral squamous cell carcinoma and cisplatin therapy. Our data suggest that the ERCC1 C118T, T118T and ERCC1 C8092A genotypes are genetic risk factors for Oral squamous cell carcinoma and ERCC1 118 C/T and C8092A polymorphisms have significant influence on clinical outcome." @default.
- W3096286885 created "2020-11-09" @default.
- W3096286885 creator A5011130047 @default.
- W3096286885 creator A5028292065 @default.
- W3096286885 creator A5048107478 @default.
- W3096286885 creator A5048782364 @default.
- W3096286885 creator A5061527884 @default.
- W3096286885 creator A5064203778 @default.
- W3096286885 date "2020-01-01" @default.
- W3096286885 modified "2023-10-17" @default.
- W3096286885 title "Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients" @default.
- W3096286885 cites W2012006201 @default.
- W3096286885 cites W2057720971 @default.
- W3096286885 cites W2065966330 @default.
- W3096286885 cites W2079620909 @default.
- W3096286885 cites W2086501419 @default.
- W3096286885 cites W2145958344 @default.
- W3096286885 cites W2434214251 @default.
- W3096286885 doi "https://doi.org/10.4103/ijpm.ijpm_964_19" @default.
- W3096286885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33154302" @default.
- W3096286885 hasPublicationYear "2020" @default.
- W3096286885 type Work @default.
- W3096286885 sameAs 3096286885 @default.
- W3096286885 citedByCount "7" @default.
- W3096286885 countsByYear W30962868852021 @default.
- W3096286885 countsByYear W30962868852022 @default.
- W3096286885 countsByYear W30962868852023 @default.
- W3096286885 crossrefType "journal-article" @default.
- W3096286885 hasAuthorship W3096286885A5011130047 @default.
- W3096286885 hasAuthorship W3096286885A5028292065 @default.
- W3096286885 hasAuthorship W3096286885A5048107478 @default.
- W3096286885 hasAuthorship W3096286885A5048782364 @default.
- W3096286885 hasAuthorship W3096286885A5061527884 @default.
- W3096286885 hasAuthorship W3096286885A5064203778 @default.
- W3096286885 hasBestOaLocation W30962868851 @default.
- W3096286885 hasConcept C104317684 @default.
- W3096286885 hasConcept C104451858 @default.
- W3096286885 hasConcept C126322002 @default.
- W3096286885 hasConcept C134935766 @default.
- W3096286885 hasConcept C135763542 @default.
- W3096286885 hasConcept C143998085 @default.
- W3096286885 hasConcept C153209595 @default.
- W3096286885 hasConcept C2776694085 @default.
- W3096286885 hasConcept C2778239845 @default.
- W3096286885 hasConcept C2779309665 @default.
- W3096286885 hasConcept C3019992690 @default.
- W3096286885 hasConcept C502942594 @default.
- W3096286885 hasConcept C54355233 @default.
- W3096286885 hasConcept C71924100 @default.
- W3096286885 hasConcept C86803240 @default.
- W3096286885 hasConceptScore W3096286885C104317684 @default.
- W3096286885 hasConceptScore W3096286885C104451858 @default.
- W3096286885 hasConceptScore W3096286885C126322002 @default.
- W3096286885 hasConceptScore W3096286885C134935766 @default.
- W3096286885 hasConceptScore W3096286885C135763542 @default.
- W3096286885 hasConceptScore W3096286885C143998085 @default.
- W3096286885 hasConceptScore W3096286885C153209595 @default.
- W3096286885 hasConceptScore W3096286885C2776694085 @default.
- W3096286885 hasConceptScore W3096286885C2778239845 @default.
- W3096286885 hasConceptScore W3096286885C2779309665 @default.
- W3096286885 hasConceptScore W3096286885C3019992690 @default.
- W3096286885 hasConceptScore W3096286885C502942594 @default.
- W3096286885 hasConceptScore W3096286885C54355233 @default.
- W3096286885 hasConceptScore W3096286885C71924100 @default.
- W3096286885 hasConceptScore W3096286885C86803240 @default.
- W3096286885 hasIssue "4" @default.
- W3096286885 hasLocation W30962868851 @default.
- W3096286885 hasLocation W30962868852 @default.
- W3096286885 hasOpenAccess W3096286885 @default.
- W3096286885 hasPrimaryLocation W30962868851 @default.
- W3096286885 hasRelatedWork W1475314997 @default.
- W3096286885 hasRelatedWork W1977382129 @default.
- W3096286885 hasRelatedWork W2015130934 @default.
- W3096286885 hasRelatedWork W2027125578 @default.
- W3096286885 hasRelatedWork W2069565619 @default.
- W3096286885 hasRelatedWork W20978967 @default.
- W3096286885 hasRelatedWork W2154914070 @default.
- W3096286885 hasRelatedWork W2246478070 @default.
- W3096286885 hasRelatedWork W2349238247 @default.
- W3096286885 hasRelatedWork W2375336624 @default.
- W3096286885 hasVolume "63" @default.
- W3096286885 isParatext "false" @default.
- W3096286885 isRetracted "false" @default.
- W3096286885 magId "3096286885" @default.
- W3096286885 workType "article" @default.